Vaccine - DelRicht Research

Vaccine

Vaccine Trials Conducted

Vaccine Participants Enrolled

Vaccine Sites Nationwide

DelRicht Has Supported 2 FDA Approvals in Vaccines

At DelRicht Research, we have a specialized network of sites focused on vaccines, offering unrivaled patient access and investigator support for your research programs. Our commitment to advancing vaccine research is reflected in our partnerships with leading physicians and healthcare facilities.

Let's talk about your next trial

Therapeutic Expertise

Our expertise in vaccine research includes, but is not limited to:

  • Avian Influenza
  • COVID-19
  • Herpes Zoster
  • Influenza
  • Norovirus
  • Pneumococcal Disease
  • Respiratory Syncytial Virus (RSV)

x5 Sites Recognized as Top Enroller Status

x2 First Patient Screened or Enrolled

Capabilities

DelRicht Research’s broad network provides access to diverse vaccine patients and supports high-quality studies with experienced physicians and staff. Key capabilities include:

  • Institutional BioSafety Committee (IBC) 
  • National Institute of Health (NIH) Registration
  • Exposure Control Plans for Genetically Modified Vaccines and/or Genetically Engineered Gene Cell Therapy
  • Bloodborne Pathogen Trained Staff
  • Tracking System to Monitor Medical Equipment, Location, Calibration, Usage, and Maintenance
  • Training Tracking System to Monitor Study Staff and Site Certifications and Licensure

 

17 Vaccine Principal Investigators

300+ Years of Collective PI Experience

Meet Some Of Our Investigators

Patrick Dennis, MD

Board Certified, Emergency Medicine

Jennifer Zomnir, MD

Board Certified, Family Medicine

Melita Tate, MD

Board Certified, Internal Medicine & Pediatric Medicine

Robert Springer, MD

Board Certified, Internal Medicine

Taylor Sanders, MD

Board Certified, Emergency Medicine

Sean Kerby, MD

Board Certified, Emergency & Family Medicine

About Our Investigators

Case Studies & Trial Highlights

First Patient

Screened Studywide in Phase 2 Avian Flu Vaccine Trial

Read More $

Trial Published

With Dr. Patrick Dennis as a Contributing Author

Read More $

FDA Approves

Moderna’s mRESVIA® for RSV in Adults Over 60

Read More $

Vaccine FDA Approvals

Vaccine

Site Network of Choice

See Our Vaccine Locations

Let's talk about your next trial.